Principal Investigator
Barbara Coffey
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230048
Clinical Trial Summary
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults with Tourettes Disorder
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Daniela Martinez
Phone Number
+1 (305) 2433110
Email
dmartinez2@miami.edu